Altria’s second quarter results were met with a notably negative market response, despite revenue aligning with Wall Street expectations and a slight year-on-year increase. Management pointed to ongoing investments in its smoke-free portfolio and continued strength in its traditional tobacco segment as key drivers this quarter. However, margins declined and non-GAAP earnings per share missed consensus, with CEO Salvatore Mancuso highlighting persistent economic pressures on consumers and increased competition in both traditional and newer nicotine segments.
Is now the time to buy MO? Find out in our full research report (it’s free for active Edge members).
Altria (MO) Q2 CY2026 Highlights:
- Revenue: $5.36 billion vs analyst estimates of $5.35 billion (1.2% year-on-year growth, in line)
- Adjusted EPS: $1.48 vs analyst expectations of $1.50 (1.2% miss)
- Management slightly raised its full-year Adjusted EPS guidance to $5.67 at the midpoint
- Operating Margin: 58.6%, down from 61.1% in the same quarter last year
- Market Capitalization: $114.3 billion
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Altria’s Q2 Earnings Call
-
Matthew Smith (Stifel) asked about the impact of stepped-up investments in on! PLUS and Cowboy Cut on second half performance. CEO Salvatore Mancuso confirmed increased investment levels and emphasized the importance of monitoring consumer health and economic pressures.
-
Bonnie Herzog (Goldman Sachs) questioned the flat benefit from duty drawback credits despite higher export volumes. CFO Heather Newman attributed this to timing factors and inventory movements, assuring that benefits should balance out in the second half.
-
Pallav Mittal (Barclays) inquired about the correlation between gas prices and cigarette volumes, and whether PM USA’s shipment outperformance would unwind. Mancuso explained that trade-down trends persist, but their portfolio approach supports share stability.
-
Eric Serotta (Morgan Stanley) sought clarification on the effect of portfolio mix shifts between premium and discount brands. Newman discussed the company’s strategy to maximize long-term profitability by balancing targeted promotions in discount and premium segments.
-
Mirza Faham Baig (UBS) asked about price realization and the effect of Cowboy Cut and FDA policy on future product launches. Mancuso cited strong Marlboro price realization and described FDA guidance as constructive for future nicotine pouch and e-vapor innovation.
Catalysts in Upcoming Quarters
In the coming quarters, our team will be watching (1) the national rollout and consumer uptake of new on! PLUS flavors and higher strength variants, (2) the impact of continued FDA enforcement and regulatory decisions on both nicotine pouches and e-vapor product launches, and (3) consumer behavior trends across premium and discount segments as economic pressures persist. Any signals of stabilization or reversal in cigarette volume declines will also be key markers for Altria’s trajectory.
Altria currently trades at $68.48, down from $74.92 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.